Autologous bone marrow support for submyeloablative chemotherapy dose intensification in canine lymphoma
โ Scribed by A.E. Frimberger; A.S. Moore; P.J. Quesenberry
- Book ID
- 114216219
- Publisher
- Elsevier Science
- Year
- 2000
- Tongue
- English
- Weight
- 29 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0301-472X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Fifteen patients with advanced breast cancer who had achieved either a good partial or a complete response to conventional chemotherapy were selected to receive intensification treatment with high-dose melphalan 140-200 mg/m2 (HDM). All patients received autologous bone marrow rescue. All patients e
Background. Patients with relapsed germ cell cancer (GCT) have a poor prognosis when treated solely with conventional chemotherapy; high dose chemotherapy with autologous bone marrow rescue (ABMR) has shown curative potential in patients with relapsed and refractory GCT. This protocol was designed t